EU pharma changes bring new responsibilities - and some confusion
This article was originally published in SRA
Executive Summary
It’s been all change in the European Union this month, most of it a result of the Lisbon Treaty: a new president of the European Council, a new position of high representative for foreign affairs and security, and now a new-look European Commission with a range of novel portfolios.